NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses
page 412
archive
Jump to
European Urology
Volume 49, issue 2, pages 209-414, February 2006Viewing articles 41-45 of 45
topWords of Wisdom
Prostate-Specific Antigen Levels in the United States: Implications of Various Definitions for Abnormal
pages 412 - 413
topThe Top Ten & Early Release
topCongress Calendar
Viewing articles 41-45 of 45
Copyright © 